Jasper Therapeutics (JSPR) Revenue & Revenue Breakdown
Jasper Therapeutics Revenue Highlights
Jasper Therapeutics Revenue by Period
Jasper Therapeutics Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
Jasper Therapeutics Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $2.05M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
Jasper Therapeutics Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
EQ | Equillium | $36.08M | $13.85M |
HOOK | HOOKIPA Pharma | $20.13M | - |
IKNA | Ikena Oncology | $9.16M | - |
INBX | Inhibrx Biosciences | $1.80M | - |
LYRA | Lyra Therapeutics | $1.56M | $598.00K |
DSGN | Design Therapeutics | - | - |
LIAN | LianBio | - | - |
ABOS | Acumen Pharmaceuticals | - | - |
INZY | Inozyme Pharma | - | - |
GRTX | Galera Therapeutics | - | - |
ELYM | Eliem Therapeutics | - | - |
EPIX | ESSA Pharma | - | - |
ORIC | ORIC Pharmaceuticals | - | - |
EWTX | Edgewise Therapeutics | - | - |
JSPR | Jasper Therapeutics | - | - |
XLO | Xilio Therapeutics | - | $2.36M |
ELDN | Eledon Pharmaceuticals | - | - |
JSPR Revenue FAQ
What is Jasper Therapeutics’s yearly revenue?
Jasper Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. JSPR's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Jasper Therapeutics’s quarterly revenue?
Jasper Therapeutics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). JSPR's quarterly revenue for Q4 2023 was $2.05M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Jasper Therapeutics’s revenue growth rate?
Jasper Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.